Skip to main content

Full Schedule

Full Schedule

  • Friday, July 1, 2022
  • 08:00 – 09:25
    Session X: Presentation of Selected Colorectal Cancer Abstracts

    Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

    Chair: Cathy Eng, MD, FACP, FASCO – Vanderbilt-Ingram Cancer Center

  • 08:00 – 09:25
    Session XI: Minisymposium: The Role of Functional Imaging in GI Cancer

    Chair: Gina Brown, MD – Imperial College

    Chair: Raquel Perez-Lopez, MD, PhD – Vall d'Hebron Institute of Oncology

  • 08:00 – 09:25
    Session XII: Minisymposium: Special Topics in Young Adults with Cancer

    Chair: Andrea Cercek, MD – Memorial Sloan Kettering Cancer Center

    Chair: Erika Ruiz-Garcia, MD, MSc – Instituto Nacional de Cancerologia

  • 08:00 – 08:45
    Session XIII: Meet the Experts: Customized Dosing for Kinase Inhibitors

    Chair: Tanios Bekaii-Saab, MD – Mayo Clinic

    Educational activity provided by ESMO WCGIC and supported by Bayer
  • 09:30 – 10:20
    Session XIV: Keynote Lectures

    Chair: Eric Van Cutsem, MD, PhD – University Hospital Gasthuisberg/Leuven

    Chair: Michel P. Ducreux, MD, PhD – Gustave Roussy

  • 10:20 – 10:50
    Break and Poster Viewing
  • 10:50 – 13:25
    Session XV: Rectal Cancer

    Chair: André JL D'Hoore, MD, PhD – University Hospital Gasthuisberg

    Chair: Deborah Mukherji, MBBS – American University of Beirut Medical Center

  • 13:40 – 15:10
    Evolving Therapeutic Strategies in Advanced GI Cancers

    Session Chair: Ruth Vera

    Supported by Amgen
  • 13:40 – 15:10
    Managing Patients with Difficult to Treat Cancers – Insights into Pancreatic Cancer and Cholangiocarcinoma

    Session Chair: Thomas T. Seufferlein, MD, PhD – Ulm University

    Supported by Servier
  • 13:40 – 15:10
    Realizing Improved Outcomes in HER2-Positive Gastrointestinal Cancers: New Evidence and Practical Guidance with Targeted Agents

    Session Chair: Elena Elez, Sr., MD PhD – Vall Hebron University Hospital

    Session Chair: Yelena Y. Janjigian, MD – Memorial Sloan Kettering Cancer Center

    Educational activity provided by PeerView Live and supported by Daiichi Sankyo, Inc.
  • 13:40 – 15:10
    See the Difference: Clinical Implications of BRAFV600E-mutant Metastatic CRC

    Session Chair: Josep Tabernero, MD – Vall d’Hebron University Hospital

    Supported by Pierre Fabre
  • 15:25 – 16:25
    Session XVI: Adjuvant Colon Cancer

    Chair: Thierry André, MD – Hopital Saint Antoine

    Chair: Alberto F. Sobrero, prof – IRCCS Ospedale San Martino IST

  • 16:30 – 17:00
    Break and Poster Viewing
  • 16:30 – 17:15
    ESMO Lounge Session: Disparities in Access to New Drugs: How to Tackle the Reality?

    Chair: Claudia Cardone, MD, PhD – Istituto Nazionale Tumori-IRCCS Fondazione "G. Pascale”

    Chair: Rille Pihlak, MD, PhD – St Bart's Hospital

    Chair: Elene Mariamidze, MD – Todua Clinic

    Speaker: Rosa Giuliani, MD – The Clatterbridge Cancer Centre

  • 16:35 – 16:55
    Poster Discussion Guided Tours - Group 4: Basic Colon Cancer (PD-11, PD-13)
  • 16:35 – 16:55
    Poster Discussion Guided Tours - Group 5: Clinical Colon Cancer (PD-12, PD-14)
  • 17:00 – 18:05
    Session XVII: Immune Mechanisms and Immunotherapy

    Chair: Mario A. Dicato, MD – Luxembourg Medical Center

    Chair: Markus Moehler, MD – Universitätsmedizin Mainz

  • 18:05 – 19:00
    Session XVIII: Predicting and Managing Rare Toxicities in GI Cancer Patients

    Chair: Sharlene Gill, MD, MPH, MBA – BC Cancer - University of British Columbia

    Chair: Juan Manuel O'Connor, MD, MSc – Instituto Alexander Fleming